You just read:

FDA Approves Allergan's sNDA for AVYCAZ® (ceftazidime and avibactam) to include new Phase III data in Patients with Complicated Urinary Tract Infections (cUTI), Including Pyelonephritis

News provided by

Allergan plc

Jan 30, 2017, 07:59 ET